Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections

Trial Profile

Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections

Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Mar 2017

At a glance

  • Drugs Tedizolid (Primary)
  • Indications Gram-positive infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 10 Mar 2017 Status changed from not yet recruiting to recruiting.
    • 07 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top